Form 4: Bausch Health Director Receives Equity Compensation

Bausch Health Companies Inc. director Amy B Wechsler received 1,065 restricted share units as compensation for her board service.

Summary

• Amy B Wechsler, a Director of Bausch Health Companies Inc. (BHC), acquired 1,065 common shares.
• The acquisition occurred on September 30, 2025, and was reported on October 2, 2025.
• These shares were issued as Restricted Share Units (RSUs) in lieu of cash compensation for her service on the Issuer's Board of Directors for the quarter ending September 30, 2025.
• Each RSU represents a contingent right to receive one common share of Bausch Health Companies Inc.
• Following this transaction, Amy B Wechsler beneficially owns a total of 265,452 common shares.

Sentiment

Score: 6

Explanation: The filing indicates a routine, expected transaction related to director compensation. While not a significant positive catalyst, it reflects ongoing corporate governance and director alignment with shareholder interests, which is generally viewed as a neutral to slightly positive signal.

Positives

• The issuance of Restricted Share Units aligns the director's interests with those of the shareholders, as her compensation is tied to the company's equity performance.
• This transaction reflects the company's standard practice of compensating board members, indicating stable corporate governance practices.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

The practice of compensating directors with equity, such as Restricted Share Units, is a common and widely accepted practice across various industries, including pharmaceuticals and healthcare, to align the interests of board members with long-term shareholder value.

Comparison to Industry Standards

• Equity compensation for non-executive directors, often in the form of RSUs, is a standard practice in publicly traded companies, including those in the healthcare sector like Bausch Health. This aligns with global benchmarks for corporate governance and executive/director compensation.
• The grant of 1,065 RSUs to a director is within the typical range for routine quarterly or annual compensation for board service in companies of similar market capitalization and industry.

Related Party Transactions

• The acquisition of 1,065 Restricted Share Units by Amy B Wechsler, a Director, constitutes a related party transaction as it involves compensation from the issuer to a member of its board.

Stakeholder Impact

• Shareholders: The issuance of equity compensation to a director helps align the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Key Dates

Keywords

Bausch Health Companies, BHC, Form 4, Insider Transaction, Director Compensation, Restricted Share Units, Equity Compensation, Corporate Governance